Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401)) is Buildings and Property in Denmark that focus on commercialization right business. They cover business area such as class, mAb, myeloid-derive suppressor cell, MDSC, neutrophil, anti-tumor immunity, solid and hematologic tumor.
-
Commercialization Right
-
Novo Allé
2880 Bagsvaerd
Denmark
Private
classmAbmyeloid-derive suppressor cellMDSCneutrophilanti-tumor immunitysolid and hematologic tumor
* We use standard office opening hours in near Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401))'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Novo Nordisk (Rights To Anti-C5aR Antibody (IPH5401)) is Buildings and Property business from Denmark that founded in - ( years old in ), Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401)) business is focusing on Commercialization Right.
Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401)) headquarter office and corporate office address is located in Novo Allé 2880 Bagsvaerd Denmark.
Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401)) was founded in Denmark.
In , Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401)) is currently focus on commercialization right sector.
Above is snippet of Google Trends for "commercialization right" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Novo Nordisk (Rights to Anti-C5aR antibody (IPH5401)), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
